EGFR and non-small cell lung carcinoma: Therefore, we conducted a real-world study to investigate the targeted outcomes of diverse EGFR TKIs in NSCLC patients with the A763_Y764insFQEA and D770delinsGY variants, and compared them with the therapeutic response in patients harboring other EGFR ex20ins subtypes.